With once-daily oral Wegovy , approximately 46% of individuals at higher doses reported nausea, followed by vomiting and constipation
Los eventos adversos graves fueron reportados por el 4,1 % de los participantes en general, con una incidencia similar entre los grupos (4,8 % con tirzepatida y 3,5 % con semaglutida)
Primary concerns include additive cardiovascular effects (tachycardia, hypertension), intensified gastrointestinal symptoms (nausea, vomiting, constipation), central nervous system effects (insomnia, anxiety), and excessive appetite suppression potentially leading to nutritional deficiencies
Healthy fats: You'll find healthy fats in oily fish like salmon, nuts, and avocado
These mechanisms result in improved glycemic control in diabetes and significant weight reduction in obesity